Abstract
Purpose
Radiotherapy-induced nausea and vomiting is a common side effect of radiotherapy. It is well-established that nausea and vomiting have a negative impact on quality of life, but the relative influence of each of symptom is infrequently reported. This study aimed to compare the effects of nausea and vomiting on quality of life in cancer patients receiving palliative radiotherapy.
Methods
The Functional Living Index-Emesis (FLIE) is a quality of life questionnaire developed in the chemotherapy-induced nausea and vomiting setting. The FLIE consists of 18 questions, half of which address nausea and half of which address vomiting. Three prospective studies on the efficacy of various anti-emetic medications conducted at our center used the FLIE to assess radiotherapy-induced nausea and vomiting at various time points during and after palliative radiotherapy. FLIE data from these three studies were combined for the present analysis. Univariate and multivariate analyses were conducted to assess the relationships between nausea and vomiting, time of FLIE completion, and patient-reported quality of life.
Results
Nausea and vomiting scores both decreased patients’ quality of life. Multivariate modeling showed that both symptoms significantly influenced patients’ ability to enjoy meals. Nausea was also associated with increased hardship for the patient, while vomiting imposed more difficulty on the patients’ loved ones.
Conclusions
Nausea and vomiting both significantly influence quality of life. Nausea seems to impact the patient more directly, whereas vomiting affects those closest to the patient.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Poon M, Dennis K, Deangelis C, Chung H (2015) Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the functional living index—emesis (FLIE) quality-of-life tool. Support Care Cancer 25:2589–2598. https://doi.org/10.1007/s00520-015-2617-9
Dennis K, Maranzano E, De AC, Holden L (2011) Radiotherapy-induced nausea and vomiting. Expert Rev Pharmacoecon Outcomes Res 11:685–692
Wong E, Pulenzas N, Bedard G, DeAngelis C, Zhang L, Tsao M, Danjoux C, Thavarajah N, Lechner B, McDonald R, Cheon PM, Chow E (2015) Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting—a pilot study. Curr Oncol 22:199–210. https://doi.org/10.3747/co.22.2395
Enblom A, Bergius Axelsson B, Steineck G, Hammar M, Börjeson S (2009) One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer 17:23–32. https://doi.org/10.1007/s00520-008-0445-x
Feyer P, Jahn F, Jordan K (2013) Radiation induced nausea and vomiting. Eur J Pharmacol 722:1–7. https://doi.org/10.1016/j.ejphar.2013.09.069
Lindley CM, Hirsch JD, O’Neill CV et al (1992) Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1:331–340. https://doi.org/10.1007/BF00434947
Dennis K, De Angelis C, Jon F et al (2014) Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study. Curr Oncol 21:e760–e767. https://doi.org/10.3747/co.21.2051
Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R (2013) Nausea still the poor relation in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer 21:735–748. https://doi.org/10.1007/s00520-012-1574-9
Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, On behalf of the ESMO/MASCC Guidelines Working Group (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21:232–243. https://doi.org/10.1093/annonc/mdq194
de Souza CM, Visacri MB, Ferrari GB, Tuan BT, Costa APL, Barbosa CR, Lima CSP, Mazzola PG, Moriel P (2015) Nausea , vomiting and quality of life of patients with cancer undergoing antineoplastic treatment : an evaluation. Int J Pharm Pract 23:357–360. https://doi.org/10.1111/ijpp.12169
Maranzano E, De Angelis V, Pergolizzi S et al (2010) A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. Radiother Oncol 94:36–41. https://doi.org/10.1016/j.radonc.2009.11.001
Feyer PC, Stewart AL, Titlbach OJ (1998) Aetiology and prevention of emesis induced by radiotherapy. Support Care Cancer 6:253–260. https://doi.org/10.1007/s005200050163
Martin AR, Carides AD, Pearson JD, Horgan K, Elmer M, Schmidt C, Cai B, Chawla SP, Grunberg SM (2003) Functional relevance of antiemetic control: experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant. Eur J Cancer 39:1395–1401. https://doi.org/10.1016/S0959-8049(03)00299-5
Acknowledgements
We thank the generous support of Bratty Family Fund, Michael and Karyn Goldstein Cancer Research Fund, Joey and Mary Furfari Cancer Research Fund, Pulenzas Cancer Research Fund, Joseph and Silvana Melara Cancer Research Fund, and Ofelia Cancer Research Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Appendix Functional Living Index-Emesis
Appendix Functional Living Index-Emesis
Rights and permissions
About this article
Cite this article
Yee, C., Drost, L., Zhang, L. et al. Impact of radiation-induced nausea and vomiting on quality of life. Support Care Cancer 26, 3959–3966 (2018). https://doi.org/10.1007/s00520-018-4286-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-018-4286-y